References
- Best, S. (2012). PMP use by Medicaid. Washington, D.C.: PDMP Center of Excellence. Retrieved from http://www.pdmpexcellence.org/sites/all/pdfs/Best.pdf
- Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011). Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine (Malden, Mass.), 12(4), 657–667. https://doi.org/10.1111/j.1526-4637.2011.01075.x
- Blumenschein, K., Fink, J., Freeman, P., James, K., Kirsh, K., Steinke, D., & Talbert, J. (2010). Review of prescription drug monitoring programs in the United States. Retrieved from http://chfs.ky.gov/NR/rdonlyres/85989824-1030-4AA6-91E1-7F9E3EF68827/0/KASPEREvaluationPDMPStatusFinalReport6242010.pdf
- Blumenschein, K., Fink, J. L., Freeman, P. R., Kirsh, K. L., Steinke, D. T., & Talbert, J. (2010). Independent evaluation of the impact and effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER). Lexington, KY:Institute for Pharmaceutical Outcomes and Policy.
- Calcaterra, S., Glanz, J., & Binswanger, I. A. (2013). National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug and Alcohol Dependence, 131(3), 263–270. https://doi.org/10.1016/j.drugalcdep.2012.11.018
- Centers for Disease Control and Prevention. (2015). Prescription drug overdose in the United States: Fact sheet. Retrieved February 4, 2015, from http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html
- Centers for Disease Control and Prevention, U. (2010). Emergency department visits involving nonmedical use of selected prescription drugs – United States, 2004–2008. MMWR. Morbidity and Mortality Weekly Report, 59(23), 705–709. Retrieved from http://www.safetylit.org/citations/index.php?fuseaction=citations.viewdetails&citationIds%5B%5D=citjournalarticle_197665_1
- Centers for Disease Control and Prevention, USA. (2011). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR. Morbidity and Mortality Weekly Report, 60(43), 1487–1492. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22048730
- Cochrane Effective Practice and Organisation of Care Group. (2013). Interrupted time series (ITS) analyses. Retrieved from http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/21 Interrupted time series analyses 2013 08 12.pdf
- Curtis, L. H., Stoddard, J., Radeva, J. I., Hutchison, S., Dans, P. E., Wright, A., & Schulman, K. A. (2006). Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. Health Services Research, 41(3 Pt 1), 837–855. https://doi.org/10.1111/j.1475-6773.2006.00511.x
- Eadie, J. (1993). New York State's triplicate prescription program. Rockville, MD: U.S. Department for HHS, NIDA. Retrieved from http://rzbl04.biblio.etc.tu-bs.de:8080/docportal/servlets/MCRFileNodeServlet/DocPortal_derivate_00001926/Monograph131.pdf#page=189
- Finklea, K., Sacco, L., & Bagalman, E. (2014). Prescription drug monitoring. Retrieved from https://www.fas.org/sgp/crs/misc/R42593.pdf
- Mahon, W. (2012). Rx for peril, The health insurance impact and risks of epidemic-level prescription-drug diversion. Washington, D.C.: PDMP Center of Excellence. Retrieved from http://www.pdmpexcellence.org/sites/all/pdfs/Mahon.pdf
- Maxwell, J. C. (2011). The prescription drug epidemic in the United States: A perfect storm. Drug and Alcohol Review, 30(3), 264–0[CE: Please check for page range]. https://doi.org/10.1111/j.1465-3362.2011.00291.x
- National Institute on Drug Abuse. (2013). DrugFacts: Cocaine. Retrieved from http://www.drugabuse.gov/publications/drugfacts/cocaine
- National Institute on Drug Abuse. (2014a). DrugFacts: Heroin. Retrieved from http://www.drugabuse.gov/publications/drugfacts/heroin
- National Institute on Drug Abuse. (2014b). DrugFacts: Nationwide Trends. Retrieved from http://www.drugabuse.gov/publications/drugfacts/nationwide-trends
- Reifler, L. M., Droz, D., Bailey, J. E., Schnoll, S. H., Fant, R., Dart, R. C., & Bucher Bartelson, B. (2012). Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Medicine (Malden, Mass.), 13(3), 434–442. https://doi.org/10.1111/j.1526-4637.2012.01327.x
- Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009). Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Substance Abuse: Research and Treatment, 3, 41–51. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3865068&tool=pmcen-trez&rendertype=abstract
- Simeone, R., & Holland, L. (2006). An evaluation of prescription drug monitoring programs. Retrieved from http://www.simeoneassociates.com/simeone3.pdf
- Substance Abuse and Mental Health Services Administration. (2015). The Treatment Episode Data Set (TEDS). Retrieved February 4, 2015, from http://wwwdasis.samhsa.gov/webt/information.htm.
- Swedlow, A., & Ireland, J. (2013). Estimated savings from enhanced opioid management controls through 3rd party payor access to the controlled substance utilization review and evaluation system (CURES). Retrieved from http://www.pdmpassist.org/pdf/CA_WC_ROI_Est_of_CURES_Jan_2013.pdf
- The PDMP Training and Technical Assistance Center. (2015). PDMP legislation and operational dates. Retrieved February 24, 2015, from http://www.pdmpassist.org/content/pdmp-legislation-operational-dates
- U.S. Census Bureau (2010). 2010 Census Urban and Rural Classification and Urban Area Criteria. Retrieved February 24, 2015 from https://www.census.gov/geo/reference/ua/urbanrural-2010.html
- Warner, M., Chen, L. H., Makuc, D. M., Anderson, R. N., & Miniño, A. M. (2011). Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief, (81), 1–8. Retrieved from http://europepmc.org/abstract/med/22617462.